21st Annual Women’s Health Annual Visit (WHAV)

Transforming Women’s Healthcare, One Visit at a Time
For over 2 decades, the Women’s Health Annual Visit (WHAV) has been the go-to platform for ob-gyns, primary care physicians (PCPs), nurse practitioners, and physician assistants to access cutting-edge education tailored specifically to women’s health.

Live Meeting

6.00 available credits

Information

September 20, 2025

08:00 AM - 05:00 PM EDT

New York Marriott Marquis
1535 Broadway, Room: Westside Salon (5th Floor), New York, New York, United States

ENROLL

Details

Presenters

Overview
Join our esteemed chairs, Barbara Dehn, NP, and Anita Nelson, MD, and connect with fellow healthcare professionals for a dynamic, interactive, and evidence-based learning experience that extends beyond the annual visit.
Why Attend WHAV 2025?
✅ Learn From Experts – Engage with world-renowned speakers and other key opinion leaders in women’s health
✅ Explore Emerging Trends – Gain insights into the latest advances in treatment, technology, and clinical guidelines
✅ Multimodal Learning – Gain exclusive access to digital content and expert-led podcasts designed to extend your live experience
✅ Networking & Collaboration – Connect with industry leaders, peers, and innovators committed to improving women’s health
Sponsorships and Exhibitors

Please reach out to Andrea Mathis at amathis@glc.healthcare for the WHAV 2025 Prospectus to learn more about sponsorship opportunities.
Advocacy Organizations
Program Schedule*
7:45 AM - 8:15 AM | Registration Check In & Breakfast
Check-in and badge pick-up
8:15 AM - 8:30 AM | Chair's Introduction

Introduction of faculty chairs and program overview
Conference goals and learning objectives

8:30 PM – 9:30 AM | Not Just a Headache: Migraine Across Women’s Lifespan

Learn how to screen for migraine, recognize hormonally influenced patterns, and guide treatment decisions based on life stage, goals, and preferences. Faculty discuss acute and preventive strategies, shared decision-making, and when to refer to specialty care.

9:30 AM – 10:30 AM | ENDOVOICE Live: Endometriosis - A Chronic Burden of Reproductive Years

Understand how delayed diagnosis, implicit bias, and care disparities impact women with endometriosis. Faculty discuss strategies to improve endometriosis diagnosis and management, including GnRH antagonist use and patient-centered care approaches.
10:30 AM – 11:30 AM | Diagnosing and Treating IBS: It Begins with One Simple Question

Learn how to diagnose and manage IBS in women by starting with one essential question about bowel habits. Gain practical tools for timely diagnosis, evidence-based treatment (non-pharmacologic and pharmacologic), and improved patient communication.
11:30 AM – 12:00 PM | Networking Break & Exhibits Open
Coffee and refreshments
Sponsor/exhibitor tables open
12:00 PM – 1:00 PM | Lunch Innovation Theater
Non-CME educational presentation
Lunch provided for attendees
Sponsor/exhibitor tables open
1:00 PM – 1:30 PM | Networking Break & Exhibits Open
Coffee and refreshments
Sponsor/exhibitor tables open
1:30 PM – 2:30 PM | Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages

Recognize how obstructive sleep apnea presents differently in women, often leading to underdiagnosis and delayed care. This session explores gender-specific screening challenges, risks during menopause and pregnancy, and tailored treatment strategies beyond CPAP.
2:30 PM – 3:30 PM | Primary Biliary Cholangitis: Shining Light on an “Invisible” Female Health Burden

Recognize how primary biliary cholangitis presents in women, with distinct patterns in symptoms, comorbidities, and complications. Gain practical strategies to identify clinical clues, confirm diagnosis, initiate timely referral, and understand the role of first- and second-line therapies to improve outcomes.

3:30 PM – 4:15 PM | Patient Advocacy Perspectives in Women’s Health Roundtable

A panel discussion among patient advocacy representatives and expert faculty regarding burning questions in women’s health, including menopause, fibroids and osteoporosis.
4:15 PM - 5:00 PM | Closing Remarks and Reception
*Subject to change
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Chair:
Barbara Dehn, NP
Nurse Practitioner
Planned Parenthood
Albany, NY
Barbara Dehn has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Advisor/Consultant: Acella, Avion, Bonafide, Pharmavite, Shield Therapeutics
Vendor: Cord Blood Registry
Anita L. Nelson, MD
Professor and Chair of Obstetrics & Gynecology
Western University of Health Sciences, Pomona
Professor Emeritus, Obstetrics & Gynecology, UCLA
Los Angeles, CA
Dr. Nelson has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Bayer, Exeltis USA, Inc, Merck, Myovant, Sumitomo Pharma America, Inc
Contracted Research: Daré Bioscience,Mylan Pharmaceuticals, Organon & Co, Sebela Pharmaceuticals, Sumitomo Pharma America, Viatris Pharmaceuticals, Inc
Faculty:
Rashmi Nisha Aurora, MD
Director of Women's Sleep Medicine Initiatives
Department of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
NYU Grossman School of Medicine
New York, NY

Dr. Aurora has no relevant relationships to disclose.

Ghada Bourjeily, MD, FCCP
Professor of Medicine, Health Services, Policy and Practice
The Warren Alpert Medical School and School of Public Health
Director of Women's Research
Brown Health University
Providence, RI

Dr. Bourjeily has no relevant relationships to disclose.
Linda Bradley, MD
Professor of Obstetrics & Gynecology and
Reproductive Medicine
Cleveland Clinic
Cleveland, OH
Dr. Bradley has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Receives Royalties: Wolters Kluwer, UpToDate
Medical Director: AAGL
Brooks D. Cash, MD
Chief, Functional Bowel Center
Baylor Scott and White
Baylor University Medical Center
Dallas, TX
Dr. Cash has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Advisor/Consultant: AbbVie, Alnylam, Ardelyx, Phathom, QOL, Regeneron, Salix, Sanofi
Gideon M. Hirschfield, MB BChir, PhD
Director, Autoimmune Liver Disease Program
Lily and Terry Horner Chair in Autoimmune Liver Disease Research
Division of Gastroenterology and Hepatology
Toronto General Hospital
Toronto, Canada
Dr. Hirschfield has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Advanz, CymaBay Therapeutics, Escient, Gilead, GSK, Intercept, Ipsen, Kowa, Mirum, Pliant
Alison Kole, MD, MPH, FAASM
Medical Director, Oak Health Concierge Sleep Telemedicine Program 
Creator/Host, Sleep Is My Waking Passion Podcast
Morristown, NJ
Dr. Kole has no relevant relationships to disclose.
Obianuju Sandra Madueke-Laveaux, MD, MPH
Associate Professor, Obstetrics & Gynecology
Division of Minimally Invasive Gynecologic Surgery
Director, Center for Advanced Treatment and Research of Uterine Fibroids
Chicago, IL
Dr. Madueke-Laveaux has no relevant relationships to disclose.
Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern
Dallas, TX
Dr. Mayo has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: CymaBay, GlaxoSmithKline, Intercept, Intra-Sana, Ipsen
Researcher: CymaBay, GlaxoSmithKline, Intercept, Ipsen, Mirum
Kimberly D. Orleck, PA-C
Director of Advanced Practice Providers
Atlanta Gastroenterology Associates
Atlanta, GA

Ms. Orleck has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: AbbVie, Ardelyx, Janssen, Lilly, Pfizer, Salix, Takeda
Amaal Starling, MD
Associate Professor of Neurology
Mayo Clinic College of Medicine & Science
Scottsdale, AZ
Dr. Starling has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: AbbVie, Allergan, Amgen, Amneal, Axsome Therapeutics, Eli Lilly, eNeura, Everyday Health, Impel, Lundbeck, MedIQ, Medscape, Miller Medical, Neurolief, Novartis, Pfizer, Salvia, Satsuma, Teva, Theranica, UpToDate, WebMD, Woodberry Associates
Jelena Pavlovic, MD, PhD
Associate Professor, Neurology
Montefiore Headache Center
Bronx, NY
Dr. Pavlovic has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research Funding: American Headache Society/Pfizer, American Heart Association
Consulting fees: AbbVie, Ipsen
Audrey Wells, MD
Sleep Medicine and Obesity Medicine Physician
Founder & CEO, Super Sleep MD
Women's Sleep Health Expert Advocate | AASM Women's Sleep Health Task Force
St. Paul, MN
Dr. Wells has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: ResMed

Patient Advocate:

Lauren R. Kornegay,
MPH Candidate at Emory University
Executive Director, Endo Black, Incorporated
Oxon Hill, MD
Reviewers/Content Planners/Authors:
- Cindy Davidson has no relevant relationships to disclose.
- Parul Yadav, MD, has no relevant relationships to disclose.
- Brian McDonough, MD, FAAFP has no relevant relationships to disclose.
Learning Objectives
Upon completion of this activity, learners should be better able to:
Overall WHAV25
- Recognize the spectrum of underdiagnosed chronic conditions in women
- Improve the diagnosis and management of medical conditions that disproportionately or uniquely affect women
- Utilize multidisciplinary approaches to address women's complex health needs
- Discuss emerging therapies and cutting-edge technologies relevant to women's health
Not Just a Headache: Migraine Across Women’s Lifespan
- Apply evidence-based criteria to improve the diagnosis of migraine in women
- Implement current guidelines and evidence to optimize migraine care across a woman’slife stages
- Evaluate strategies to reduce disparities and improve the quality of migraine treatment across special patient populations
- Integrate patient goals and evidence to improve shared decision-making in women with migraine
ENDOVOICE Live: Endometriosis - A Chronic Burden of Reproductive/Years
- Analyze how early diagnosis of endometriosis can improve both psychosocial and physical outcomes for patients
- Integrate patient-centered diagnostic and evaluation tools into clinical practice to support accurate assessment and shared decision-making in endometriosis care
- Implement shared decision-making strategies and patient-centered treatment to deliver equitable care for individuals with endometriosis
- Evaluate the clinical benefits and limitations of GnRH antagonists in the medical management of endometriosis
Diagnosing and Treating IBS: It Begins with One Simple Question
- Identify the components of the diagnostic process for IBS.
- Use evidence-based clinical decision tools to diagnose IBS-C.
- Use evidence-based clinical decision tools to diagnose IBS-D.
- Identify the most important factors that influence satisfaction with medical care in women with IBS.
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
- Identify obstructive sleep apnea (OSA) in women by recognizing atypical presentations
- Integrate validated assessment tools into clinical practice to improve the timely diagnosis and treatment of OSA
- Describe the increased risk of OSA in women in menopause, including the role of hormonal changes, changes in body composition, and the impact on cardiometabolic health
- Identify pregnant patients at high risk for OSA
- Recognize the range of treatment options for OSA, including CPAP alternatives and adjunctive therapies like weight-loss medications, to better inform referral decisions for comprehensive patient care
Primary Biliary Cholangitis: Shining Light on an “Invisible” Female Health Burden  
- Recognize the common phenotype of PBC
- Determine clinical information needed to make a diagnosis of PBC
- Use available clinical information to determine when to refer a patient to a specialist
- Summarize the benefits of recently approved second-line therapies for PBC
Target Audience
This activity has been designed to meet the educational needs of ob-gyns and ob-gyn advanced practice nurses as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare professionals who manage the health needs of women.
Accreditation and Credit Designation Statements

In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 6.0 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 6.0 contact hour(s)/0.6 CEUs of pharmacy contact hour(s).

The Universal Activity Number for this program is JA0006235-0000-25-057-L01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.0 AAPA Category 1 CME credit(s). PAs should claim only the credit commensurate with the extent of their participation in the activity.
Provider(s)/Educational Partner(s)

Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.
Commercial Support
This activity is supported by independent educational grants from AbbVie, Inc., Bausch Health, Eli Lilly & Company, Gilead Sciences, Inc., Ironwood Pharmaceuticals, and Sumitomo Pharma America, Inc.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
ADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.

Barbara Dehn, WHNP-BC

Anita L. Nelson, MD

Linda Bradley, MD

Alison Kole, MD, MPH, FACCP

Rashmi Nisha Aurora, MD

Ghada Bourjeily, MD, FCCP

Audrey Wells, MD

Obianuju Sandra Madueke-Laveaux, MD, MPH

Lauren R. Kornegay

Brooks D. Cash, MD

Kimberly D. Orleck, PA-C

Gideon Hirschfield, MB, BChir, PhD

Marlyn Mayo, MD

Amaal J. Starling, MD

Jelena Pavlović, MD, PhD